Patient specific biomimetic materials for bone regeneration
Over 2 million bone grafting procedures are performed annually worldwide nearly half of them in the EU, being the 2nd most transplanted tissue after blood. Bone defects pose a great clinical and socio-economic problem, only worsen...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
REGENERBONE
REGENERATING LARGE BONE DEFECTS
150K€
Cerrado
REBORNE
Regenerating Bone defects using New biomedical Engineering a...
15M€
Cerrado
PID2019-103892RB-I00
NUEVAS TECNOLOGIAS PARA EL DESARROLLO DE INJERTOS OSEOS OSTE...
363K€
Cerrado
DI-15-08184
Desarrollo de biomateriales biomiméticos para la regeneració...
65K€
Cerrado
VASCUBONE
Construction kit for tailor made vascularized boneimplants
16M€
Cerrado
BIO-INSPIRE
BIO INSPIRED BONE REGENERATION
4M€
Cerrado
Información proyecto Bone3Dmatch
Duración del proyecto: 41 meses
Fecha Inicio: 2019-04-24
Fecha Fin: 2022-09-30
Líder del proyecto
MIMETIS BIOMATERIALS
El desarrollo y comercializacion de productos,tecnologia y servicios en el campo de biomateriales y aplicaciones biomedicas
TRL
4-5
| 160K€
Presupuesto del proyecto
1M€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Over 2 million bone grafting procedures are performed annually worldwide nearly half of them in the EU, being the 2nd most transplanted tissue after blood. Bone defects pose a great clinical and socio-economic problem, only worsening with the ageing population. Even if bone harvested from the patient, bone banks or animals are common standard, they present serious disadvantages (limited availability, immune responses, disease transmission, ethical issues). Various synthetic bone grafts have been developed to minimize complications, yet with low success and failing to accelerate natural bone growth.
Bone3Dmatch revolutionizes the market of bone grafting (3.2bn€ globally) with a new generation of synthetic biomaterials. Two main disruptions are brought forward:
1) Biomimicry: The biomaterial, its aqueous composition and low-temperature processing is capable of mimicking the bone creation conditions. Thus, it is recognised as natural bone by bone cells, accelerating the bone regeneration and the patient’s recovery.
2) Patient customisation: Through advanced 3D printing technologies, it manufactures patient-specific scaffolds in less than 72h. This enables the treatment of complex bone defects, changing the current paradigm to a patient specific treatment.
The company behind Bone3Dmatch is MIMETIS, a young SME built on the back of 25 years of research and business acumen in biomaterials for bone regeneration. Currently, MIMETIS offers biomimetic granules for the dental market. With an investment of 1.1M€, Bone3Dmatch will accelerate the market introduction of the 4th generation biomaterial in a completely new form (3D-printed scaffolds). Targeting orthopaedics and cranio-maxillofacial, we expect to reach the market in 2020 achieving 4,9M€ in revenues in only 3 years. Moreover, our ambition is to deploy a decentralised model where hospitals around the world are able to print their own patient-specific implants using our biomimetic biomaterial.